402 related articles for article (PubMed ID: 12675851)
1. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
Liang K; Vaziri ND
Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
[TBL] [Abstract][Full Text] [Related]
3. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
6. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
Sato T; Liang K; Vaziri ND
Kidney Int; 2002 Jan; 61(1):157-62. PubMed ID: 11786096
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
9. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.
Vaziri ND; Liang K
Kidney Int; 2002 May; 61(5):1769-75. PubMed ID: 11967026
[TBL] [Abstract][Full Text] [Related]
11. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
Sato T; Liang K; Vaziri ND
Kidney Int; 2003 Nov; 64(5):1780-6. PubMed ID: 14531811
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Vaziri ND; Liang K; Parks JS
Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
[TBL] [Abstract][Full Text] [Related]
13. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cholesterol metabolism in human obesity.
Ståhlberg D; Rudling M; Angelin B; Björkhem I; Forsell P; Nilsell K; Einarsson K
Hepatology; 1997 Jun; 25(6):1447-50. PubMed ID: 9185766
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary soybean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats.
LeBlanc MJ; Brunet S; Bouchard G; Lamireau T; Yousef IM; Gavino V; Lévy E; Tuchweber B
J Nutr Biochem; 2003 Jan; 14(1):40-8. PubMed ID: 12559476
[TBL] [Abstract][Full Text] [Related]
16. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.
Rodríguez-Iturbe B; Sato T; Quiroz Y; Vaziri ND
Kidney Int; 2004 Aug; 66(2):668-75. PubMed ID: 15253721
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
18. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
20. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia.
Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]